GlaxoSmithKline PLC Director Declaration (3494M)
20 September 2021 - 11:42PM
UK Regulatory
TIDMGSK
RNS Number : 3494M
GlaxoSmithKline PLC
20 September 2021
GlaxoSmithKline plc
Director Declaration
GlaxoSmithKline plc announces, pursuant to the Financial Conduct
Authority's Listing Rule 9.6.14(2), that Dr Vivienne Cox CBE,
Non-Executive Director, has been appointed as a non-executive
director and Chair-designate of Victrex plc with effect from 1
December 2021 and 1 January 2022 respectively. Dr Cox will assume
responsibility as Chair of Victrex plc with effect from 11 February
2022.
V A Whyte
Company Secretary
20 September 2021
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RDNEADNEALEFEFA
(END) Dow Jones Newswires
September 20, 2021 09:42 ET (13:42 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024